<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03987529</url>
  </required_header>
  <id_info>
    <org_study_id>H1906-096-1040</org_study_id>
    <nct_id>NCT03987529</nct_id>
  </id_info>
  <brief_title>Effects of Volatile and Intravenous Anesthetics on Pupillary Function</brief_title>
  <official_title>Comparison of Effects of Volatile and Intravenous Anesthetics on Pupillary Function During General Anesthesia in Children; a Prospective Observational Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare of effects of volatile and intravenous anesthetics on pupillary function during
      general anesthesia in children
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will measure the pupillary function with pupillometry during general
      anesthesia with volatile or intravenous anesthetics in children.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 16, 2020</start_date>
  <completion_date type="Anticipated">October 11, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 11, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NPi</measure>
    <time_frame>1hour afer skin incision</time_frame>
    <description>Neurological Pupil index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>%CH</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>% change of pupil size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CV</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Constriction Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DV</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Dilation Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NPi</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Neurological Pupil index</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Pupillary Functions, Abnormal</condition>
  <arm_group>
    <arm_group_label>Sevoflurane+Remifentanil</arm_group_label>
    <description>Using inhalent agent(Sevoflurane), continuous infusion of Remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol+Remifentanil</arm_group_label>
    <description>Using continuous infusion of Propofol and Remifentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>volatile anesthetic</description>
    <arm_group_label>Sevoflurane+Remifentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>intravenous anesthetic</description>
    <arm_group_label>Propofol+Remifentanil</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From other study results, average NPi for Sevoflurane and propofol were 3.6, 4.2, and
        standard deviation was 0.1, 0.4 respectively. Using Gpower program, total of 18 patients
        were required. Considering 20% of drop-out rate, total of 22 patients(18+3.6 patients) were
        to be recruited.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients undergoing general anesthesia

        Exclusion Criteria:

          -  If injection of any agents that can change pupil size or index

          -  Any severe side effects, adverse drug reaction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pupil Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

